Olivier Petricoul Selected Research

Mobility Limitation (Difficulty Walking)

9/2017

Treatment of Sarcopenia with Bimagrumab: Results from a Phase II, Randomized, Controlled, Proof-of-Concept Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Olivier Petricoul Research Topics

Disease

4	Obesity 01/2023 - 01/2018
3	Sarcopenia 10/2020 - 09/2017
2	Insulin Resistance 01/2021 - 01/2018
1	COVID-19 06/2023
1	Multiple Sclerosis 06/2023
1	Severe Acute Respiratory Syndrome 06/2023
1	Disease Progression 06/2023
1	Overweight 01/2021
1	Type 2 Diabetes Mellitus (MODY) 01/2021
1	Wasting Syndrome (Wasting Disease) 10/2020
1	Fatigue 01/2019
1	X-Linked Bulbo-Spinal Atrophy 12/2018
1	Neuromuscular Diseases (Neuromuscular Disease) 12/2018
1	Body Weight (Weight, Body) 01/2018
1	Mobility Limitation (Difficulty Walking) 09/2017
1	Acne Vulgaris 09/2017
1	Diarrhea 09/2017
1	Migraine Disorders (Migraine) 01/2002

Drug/Important Bio-Agent (IBA)

6	bimagrumabIBA 01/2023 - 09/2017
2	Monoclonal AntibodiesIBA 01/2023 - 01/2021
1	Fingolimod Hydrochloride (FTY720)FDA Link 06/2023
1	siponimodIBA 06/2023
1	Sphingosine-1-Phosphate ReceptorsIBA 06/2023
1	Activins (Activin)IBA 01/2023
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2021
1	Anabolic AgentsIBA 10/2020
1	ianalumabIBA 01/2019
1	Therapeutic UsesIBA 01/2019
1	Androgen Receptors (Androgen Receptor)IBA 12/2018
1	Insulin-Like Growth Factor I (IGF-1)IBA 12/2018
1	Insulin (Novolin)FDA Link 01/2018
1	Glucose (Dextrose)FDA LinkGeneric 01/2018
1	Serotonin (5 Hydroxytryptamine)IBA 01/2002
1	Sumatriptan (Imigran)FDA LinkGeneric 01/2002

Therapy/Procedure

1	Critical Care (Surgical Intensive Care) 06/2023
1	Glycemic Control 01/2021